Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder
BackgroundIn the treatment of depression, medication plays a crucial role. However, insufficient patient adherence to medication often results in unsatisfactory treatment outcomes, increasing both the recurrence and rehospitalization rates of depression, and consequently imposing a greater economic...
Saved in:
| Main Authors: | Chaoli Chen, Yang Lun, Jing Yu, Xiaochuan Zhao, Shi Su, Mengqiang Zhao, Yuhang Yan, Jiaqi Wang, Ran Fu, Feiyue An, Liguang Duan, Leting Yan, Ruxing Li, Jinxiao Li, Ziyu Liu, Xiaoying Geng, Jincheng Wang, Yuanyuan Zhao, Chunhua Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1501381/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01) -
Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01) -
Exploring the preparedness of hospital pharmacists practising in Southwest London for implementing pharmacogenomics testing
by: Thuy Mason, et al.
Published: (2024-12-01) -
Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01) -
Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
by: Jaeseong Oh, et al.
Published: (2018-09-01)